A s a result of newly industrializing countries implementing public health programs to reduce the health burden from infectious diseases, greater attention is being turned to the increasing problem of chronic diseases, such as cancer, diabetes and cardiovascular disease. Cancer, in particular, has been shown to be on the rise in developing countries, especially in Asia, where it is estimated that by 2020 about half of the new cases of cancer in the world each year will occur. 1 There are several reasons why the cancer burden will increase in developing countries at a greater rate than is likely to occur in developed countries in the future. The most important factors will be population growth and the rising life expectancy, both of which are increasing more rapidly in developing countries, the latter primarily due to reduction in mortality from infectious diseases. Other important factors for the increasing problem of cancer in developing over developed countries include a higher persistence of cancer risk factors, such as cigarette smoking, and poorly developed cancer screening programs. 2 Another increasingly important, but less recognised, factor is the increase in workplace exposure to carcinogens in newly industrializing countries. Industries involving exposure to workplace carcinogens, especially those in the manufacturing sector, have been the subject of increasing regulation in developed countries. This has resulted in these types of industries, such as tyre production and asbestos related industries, being transferred to less developed countries, where labour costs are lower, there are larger pools of potential workers due to high population growth and occupational health regulation is usually not as stringent. 3 While data on exposure prevalence and level are scanty, there are indications that worker exposure to carcinogens may be higher in newly industrialising countries than in developed countries. Firstly, occupational exposure levels are higher than what is considered acceptable in most developed countries and the regulatory response to control workplace exposure to carcinogens in newly industrialising countries, especially in Asia, has been slow. 4 In China, for example, occupational exposure limits (OELs) for common workplace carcinogens, such as asbestos and crystalline silica, are about an order of 241
magnitude higher than workplace standards for these hazards in most developed countries and effective government enforcement of even these less stringent standards is a problem. 5 Many other countries in Asia have also established OELs for workplace carcinogens which are considerably higher than those thought to be acceptable in developed countries. 6 Furthermore, workplaces in newly industrialising countries in Asia have problems even complying with these unsafe OELs. 7 There is a very active international effort to identify those workplace substances which can cause cancer. The International Agency for Research on Cancer (IARC) has for may years undertaken a Monograph program whereby the published scientific evidence is reviewed and workplace and other agents classified as to their carcinogenicity to humans. 8 To date, more than 200 chemical, physical and other agents have been classified as definitely (Group 1) or probably (Group 2A) carcinogenic to humans and a high proportion of these agents are used in industrial processes.
Based on the IARC classification and applying an attributable risk fraction approach, estimates have been made of the community burden of occupational diseases, including cancer, in the comparative risk assessment for global burden of disease undertaken by the World Health Organisation (WHO). 9 The attributable fraction for occupational causes of some types of cancer has been estimated to be up to about 10%, but these estimates have usually been based on the exposure profile for workplace carcinogens in developed countries. The lack of exposure data for workplaces in developing countries makes it more difficult to estimate the attributable fractions in these countries. In the absence of effective controls on exposure in newly industrialising countries, and considering the latency between carcinogen exposure and cancer, there is the potential for higher attributable fractions and burden of occupational cancer in Asia and the Pacific in the coming decades.
Based on these estimates, the WHO has conservatively estimated that about 200,000 workers die from cancer related to their workplace each year, an increasing proportion of whom is in the developing world. 10 The WHO has become so concerned about this problem that in 2007 it developed a program for the prevention of cancer through healthy workplaces, including a call for interventions such as using benzene-free solvents, converting chromium to non-carcinogenic forms, banning tobacco use in workplaces and the use of protective clothing for workers in the sun. The impact of this program is yet to be evaluated.
The other major part of the WHO call for action to prevent workplace cancers was to stop the use of asbestos. Asbestos use in workplaces emphasises the growing problem of occupational cancer and the difficulties in its prevention in newly industrialising countries. While most developed countries have implemented complete bans on the use of asbestos, use in many developing countries, especially in Asian countries such as China and India, is continuing. It has been clearly demonstrated that in those countries which introduced early bans on asbestos use, the reduction in mesothelioma rates have been the most dramatic. 11 Unfortunately, while major asbestos producing countries, such as Canada, continue to play down the risks of chrysotile asbestos and obstruct the implementation of worldwide bans, newly industrialising countries in Asia are likely to suffer an increasing burden of asbestos related cancers in the future, 12, 13 especially as there are many barriers to the safe use of asbestos in these countries. 14 Much of the aetiological research related to occupational cancers has come from the developed world, but such data are also relevant to cancer control in workplaces in newly industrialising countries. However, local studies are also needed to identify risk factors and racial, nutritional, lifestyle and other factors which may influence the level of risk, although many challenges exist to undertake high quality research in these countries. 15 A major research gap is the lack of reliable workplace exposure data, which hampers attempts to obtain reliable estimates of the extent of occupational cancers and the effectiveness of interventions. To help fill these gaps, the Asia Pacific Journal of Public Health welcomes research papers related to studies of all aspects of workplace related cancers throughout the Asia Pacific region. We also call upon the public health community in the region to support efforts to more effectively control exposure to workplace carcinogens in their countries.
